Cited by 166Inflammatory Bowel DiseaseGenetic Associations and EpidemiologyMultiple Sclerosis Research Studies

Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn's disease

Open access
Marigorta, Urko M, Denson, Lee A, Hyams, Jeffrey S, Mondal, Kajari, Prince, Jarod, Walters, Thomas D, Griffiths, Anne, Noe, Joshua D +15 more·2017·Nature Genetics

Abstract

Gene expression profiling can be used to uncover the mechanisms by which loci identified through genome-wide association studies (GWAS) contribute to pathology. Given that most GWAS hits are in putative regulatory regions and transcript abundance is physiologically closer to the phenotype of interest, we hypothesized that summation of risk-allele-associated gene expression, namely a transcriptional risk score (TRS), should provide accurate estimates of disease risk. We integrate summary-level GWAS and expression quantitative trait locus (eQTL) data with RNA-seq data from the RISK study, an inception cohort of pediatric Crohn's disease. We show that TRSs based on genes regulated by variants linked to inflammatory bowel disease (IBD) not only outperform genetic risk scores (GRSs) in distinguishing Crohn's disease from healthy samples, but also serve to identify patients who in time will progress to complicated disease. Our dissection of eQTL effects may be used to distinguish genes whose association with disease is through promotion versus protection, thereby linking statistical association to biological mechanism. The TRS approach constitutes a potential strategy for personalized medicine that enhances inference from static genotypic risk assessment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ng.3936

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The study developed a proteomic risk score by selecting PWAS-significant aptamers (n=456) and performing LASSO regression to select predictors of AD status (Npredictors=100) in a training dataset (n=1,325).

    “We developed a proteomic risk score91 by selecting PWAS-significant aptamers (n=456) and performing LASSO regression to select predictors of AD status (Npredictors=100) in a training dataset (n=1,325).”

    From Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease (2024) · cites this paper as [91]

    The Introductory Paragraph describes a transcriptional risk score derived from gene expression for predicting Crohn’s disease outcomes, providing a precedent for a molecular risk score. It does not describe a proteomic score, PWAS-significant aptamers, LASSO selection, Alzheimer’s disease status, or the stated predictor and training-set counts; those details concern the citing authors’ study, not this source. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 39

  1. [1]Fairfax BP Knight JC Genetics of gene expression in immunity to infection Curr Opin Immunol 30 63 71 2014 25078545 PMC4426291
  2. [2]Gibson G Powell JE Marigorta UM Expression quantitative trait locus analysis for translational medicine Genome Med 7 60 2015 26110023 PMC4479075
  3. [3]Haberman Y Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature J Clin Invest 124 3617 33 2014 25003194 PMC4109533
  4. [4]Kugathasan S Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study Lancet 2017 PMC5719489 28259484
  5. [5]Witte JS Visscher PM Wray NR The contribution of genetic variants to disease depends on the ruler Nat Rev Genet 15 765 76 2014 25223781 PMC4412738
  6. [7]Wray NR Goddard ME Visscher PM Prediction of individual genetic risk to disease from genome-wide association studies Genome Res 17 1520 8 2007 17785532 PMC1987352
  7. [8]Chatterjee N Shi J Garcia-Closas M Developing and evaluating polygenic risk prediction models for stratified disease prevention Nat Rev Genet 17 392 406 2016 27140283 PMC6021129
  8. [9]Walters TD Increased effectiveness of early therapy with anti-tumor necrosis factor-alpha vs an immunomodulator in children with Crohn's disease Gastroenterology 146 383 91 2014 24162032
  9. [10]Liu JZ Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations Nat Genet 47 979 86 2015 26192919 PMC4881818
  10. [11]Westra HJ Systematic identification of trans eQTLs as putative drivers of known disease associations Nat Genet 45 1238 43 2013 24013639 PMC3991562
  11. [12]Kabakchiev B Silverberg MS Expression quantitative trait loci analysis identifies associations between genotype and gene expression in human intestine Gastroenterology 144 1488 96 1496 e1 3 2013 23474282 PMC3775712
  12. [13]GTEx Consortium The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans Science 348 648 60 2015 25954001 PMC4547484
  13. [14]Di Narzo AF Blood and Intestine eQTLs from an Anti-TNF-Resistant Crohn's Disease Cohort Inform IBD Genetic Association Loci Clin Transl Gastroenterol 7 e177 2016 27336838 PMC4931595
  14. [17]Zhu Z Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets Nat Genet 48 481 7 2016 27019110
  15. [18]Lee JC Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease Nat Genet 49 262 268 2017 28067912 PMC5730041
  16. [19]Ning K Improved integrative framework combining association data with gene expression features to prioritize Crohn's disease genes Hum Mol Genet 24 4147 57 2015 25935003 PMC4560067
  17. [20]Singh T Characterization of expression quantitative trait loci in the human colon Inflamm Bowel Dis 21 251 6 2015 25569741 PMC4345969
  18. [22]Gibson G Weir B The quantitative genetics of transcription Trends Genet 21 616 23 2005 16154229
  19. [23]de Souza HS Fiocchi C Immunopathogenesis of IBD: current state of the art Nat Rev Gastroenterol Hepatol 13 13 27 2016 26627550
  20. [24]McGovern DP Kugathasan S Cho JH Genetics of Inflammatory Bowel Diseases Gastroenterology 149 1163 1176 e2 2015 26255561 PMC4915781
  21. [25]Nabekura T Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection Immunity 40 225 34 2014 24440149 PMC3943894
  22. [26]Martinet L Smyth MJ Balancing natural killer cell activation through paired receptors Nat Rev Immunol 15 243 54 2015 25743219
  23. [27]Petrillo MG GITR+ regulatory T cells in the treatment of autoimmune diseases Autoimmun Rev 14 117 26 2015 25449679
  24. [28]Reikvam DH Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients Scand J Gastroenterol 46 550 60 2011 21281255
  25. [29]Ye CJ Intersection of population variation and autoimmunity genetics in human T cell activation Science 345 1254665 2014 25214635 PMC4751028
  26. [30]Wiley SE The outer mitochondrial membrane protein mitoNEET contains a novel redox-active 2Fe-2S cluster J Biol Chem 282 23745 9 2007 17584744
  27. [31]Novak EA Mollen KP Mitochondrial dysfunction in inflammatory bowel disease Front Cell Dev Biol 3 62 2015 26484345 PMC4589667
  28. [32]Levine A Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification Inflamm Bowel Dis 17 1314 21 2011 21560194
  29. [33]Satsangi J Silverberg MS Vermeire S Colombel JF The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications Gut 55 749 53 2006 16698746 PMC1856208
  30. [34]Cleynen I Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study Lancet 387 156 67 2016 26490195 PMC4714968
  31. [35]Kim D TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions Genome Biol 14 R36 2013 23618408 PMC4053844
  32. [36]Li H The Sequence Alignment/Map format and SAMtools Bioinformatics 25 2078 9 2009 19505943 PMC2723002
  33. [37]Anders S Pyl PT Huber W HTSeq--a Python framework to work with high-throughput sequencing data Bioinformatics 31 166 9 2015 25260700 PMC4287950
  34. [38]Robinson MD McCarthy DJ Smyth GK edgeR: a Bioconductor package for differential expression analysis of digital gene expression data Bioinformatics 26 139 40 2010 19910308 PMC2796818
  35. [40]Onengut-Gumuscu S Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers Nat Genet 47 381 6 2015 25751624 PMC4380767
  36. [41]Leek JT Johnson WE Parker HS Jaffe AE Storey JD The sva package for removing batch effects and other unwanted variation in high-throughput experiments Bioinformatics 28 882 3 2012 22257669 PMC3307112
  37. [42]Mecham BH Nelson PS Storey JD Supervised normalization of microarrays Bioinformatics 26 1308 15 2010 20363728 PMC2865860
  38. [44]Chun S Limited statistical evidence for shared genetic effects of eQTLs and autoimmune-disease-associated loci in three major immune-cell types Nat Genet 49 600 605 2017 28218759 PMC5374036
  39. [45]Lee MN Common genetic variants modulate pathogen-sensing responses in human dendritic cells Science 343 1246980 2014 24604203 PMC4124741

Cited by

Sorted by citations

Authors
Marigorta, U. M., Denson, L. A., Hyams, J. S., Mondal, K., Prince, J., Walters, T. D., Griffiths, A., Noe, J. D., Crandall, W. V., Rosh, J. R., Mack, D. R., Kellermayer, R., Heyman, M. B., Baker, S. S., Stephens, M. C., Baldassano, R. N., Markowitz, J. F., Kim, M.-O., Dubinsky, M. C., Cho, J., Aronow, B. J., Kugathasan, S., & Gibson, G.
Affiliations
  • Georgia Institute of Technology (US)
  • Cincinnati Children's Hospital Medical Center (US)
  • Connecticut Children's Medical Center (US)
  • Emory University (US)
  • University of Toronto (CA)
  • Medical College of Wisconsin (US)
  • Nationwide Children's Hospital (US)
  • Goryeb Children's Hospital (US)
  • University of Ottawa (CA)
  • University of California, San Francisco (US)
  • University at Buffalo, State University of New York (US)
  • Mayo Clinic (US)
  • University of Pennsylvania (US)
  • Northwell Health (US)
  • Mount Sinai Hospital (US)
Corresponding author
Gibson, Greg
Venue
Nature Genetics
Published
2017-08-14
Volume
49
Issue
10
Pages
1517-1521
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2746163443
Cited by
166
References
6
Citations by year
2026: 10 · 2025: 14 · 2024: 18 · 2023: 20 · 2022: 11 · 2021: 27 · 2020: 12 · 2019: 31 · 2018: 20 · 2017: 3
FWCI
11.70
Type
journal article
Language
en
Open access
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Crohn's and Colitis Foundation (274356, 292052, 419130)
  • National Institute of General Medical Sciences (P01GM099568)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK078392)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
Keywords
Crohn's disease, expression quantitative trait loci, polygenic risk score, pediatric inflammatory bowel disease, disease progression prediction, gene expression, regulatory variants, personalized medicine, risk research
MeSH terms
Alleles, Child, Crohn Disease, Gene Expression Regulation, Humans, Ileum, Models, Genetic, Prognosis, RNA, Messenger, Transcription, Genetic, Inflammatory Bowel Diseases, Age of Onset, Disease Progression, Risk Assessment, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Gene Expression Profiling, Quantitative Trait Loci, Genome-Wide Association Study, Observational Studies as Topic, Datasets as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review